Table 2.
Intrathecal therapy
|
Age
|
||||
|---|---|---|---|---|
| Less than 2 y | 2 y | 3 to 8 y | More than 8 y | |
| IT MTX, mg | 8 | 10 | 12 | 12 |
| ITT | ||||
| MTX, mg | 8 | 10 | 12 | 15 |
| Cytarabine, mg | 16 | 20 | 24 | 30 |
| HSS, mg | 8 | 10 | 12 | 15 |
Intrathecal therapy
|
Age
|
||||
|---|---|---|---|---|
| Less than 2 y | 2 y | 3 to 8 y | More than 8 y | |
| IT MTX, mg | 8 | 10 | 12 | 12 |
| ITT | ||||
| MTX, mg | 8 | 10 | 12 | 15 |
| Cytarabine, mg | 16 | 20 | 24 | 30 |
| HSS, mg | 8 | 10 | 12 | 15 |